Core B will provide support for all of the animal experiments in Projects 1 and 2 of the proposal. It includes oversight of quality control of ali aspects of animal purchases, maintenance of the animal colony, breeding of mice, UM Unit for Laboratory Animal Medicine regulatory communications, experimental transplantation of mice, and histopathological analysis. It is designed to enhance harmonization and efficiency of the experiments that utilize animals in Projects 1 and 2. The services provided by Core B are: 1. To oversee and monitor adherence to the standards required by the University of Michigan Unit for Laboratory Animal Medicine (ULAM) 2. To facilitate centralized and orderly animal purchases and provide for routine but uniform pretransplant and post-BMT animal care and specialized breeding ofthe knock-out mice 3. To prepare donor cell inoculums and perform BMT following irradiation in a standardized manner 4. To provide supervision for consistent scoring of clinical GVHD in the transplant models 5. To provide standardized harvesting of target organs, processing, staining (hematoxylin and eosin) and shipping of samples for histopathological analysis by Dr. Chen Liu at the University of Florida 6. To provide uniform and consistent histologic analysis of GVHD pathology in target organ tissues
Allogeneic hematopoietic stem cell transplantation is a potentially curative therapy for many malignant diseases whose applicability has been impeded by the development of its most serious complication, GVHD. Strategies that mitigate GVHD will allow for better harnessing of this effective therapeutic modality to treat many patients with hematological cancers.
| Holtan, Shernan G; DeFor, Todd E; Panoskaltsis-Mortari, Angela et al. (2018) Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. Blood Adv 2:1882-1888 |
| Ortiz-Velez, Laura; Ortiz-Villalobos, Javiera; Schulman, Abby et al. (2018) Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri. Microb Cell Fact 17:138 |
| Ferrara, James L M; Chaudhry, Mohammed S (2018) GVHD: biology matters. Hematology Am Soc Hematol Educ Program 2018:221-227 |
| Major-Monfried, Hannah; Renteria, Anne S; Pawarode, Attaphol et al. (2018) MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood 131:2846-2855 |
| Naymagon, Steven; Naymagon, Leonard; Wong, Serre-Yu et al. (2017) Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol 14:711-726 |
| Hartwell, Matthew J; Özbek, Umut; Holler, Ernst et al. (2017) An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight 2:e89798 |
| Stickel, N; Hanke, K; Marschner, D et al. (2017) MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation. Leukemia 31:2732-2741 |
| Ferrara, James Lm; Smith, Christopher M; Sheets, Julia et al. (2017) Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest 127:2441-2451 |
| Miller, Holly K; Braun, Thomas M; Stillwell, Terri et al. (2017) Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 23:522-528 |
| Renteria, Anne S; Levine, John E; Ferrara, James L M (2016) Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease. Expert Opin Orphan Drugs 4:469-484 |
Showing the most recent 10 out of 231 publications
